Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

The direct relationship between inhibitory currents and local field potentials.

Trevelyan AJ.

J Neurosci. 2009 Dec 2;29(48):15299-307. doi: 10.1523/JNEUROSCI.2019-09.2009.

2.

Magnetic resonance imaging reveals that galantamine prevents structural brain damage induced by an acute exposure of guinea pigs to soman.

Gullapalli RP, Aracava Y, Zhuo J, Helal Neto E, Wang J, Makris G, Merchenthaler I, Pereira EF, Albuquerque EX.

Neurotoxicology. 2010 Jan;31(1):67-76. doi: 10.1016/j.neuro.2009.09.004. Epub 2009 Sep 24.

PMID:
19782102
3.

Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine.

Aracava Y, Pereira EF, Akkerman M, Adler M, Albuquerque EX.

J Pharmacol Exp Ther. 2009 Dec;331(3):1014-24. doi: 10.1124/jpet.109.160028. Epub 2009 Sep 9.

4.

Mammalian nicotinic acetylcholine receptors: from structure to function.

Albuquerque EX, Pereira EF, Alkondon M, Rogers SW.

Physiol Rev. 2009 Jan;89(1):73-120. doi: 10.1152/physrev.00015.2008. Review.

5.

A single in vivo application of cholinesterase inhibitors has neuron type-specific effects on nicotinic receptor activity in guinea pig hippocampus.

Alkondon M, Aracava Y, Pereira EF, Albuquerque EX.

J Pharmacol Exp Ther. 2009 Jan;328(1):69-82. doi: 10.1124/jpet.108.146068. Epub 2008 Oct 8.

6.

Presynaptic signaling by heterotrimeric G-proteins.

Brown DA, Sihra TS.

Handb Exp Pharmacol. 2008;(184):207-60. Review.

PMID:
18064416
7.

Muscarinic receptor dysfunction induced by exposure to low levels of soman vapor.

Dabisch PA, Horsmon MS, Muse WT, Mioduszewski RJ, Thomson S.

Toxicol Sci. 2007 Nov;100(1):281-9. Epub 2007 Aug 9.

8.
9.

Nerve agents.

Newmark J.

Neurologist. 2007 Jan;13(1):20-32. Review.

PMID:
17215724
10.

Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.

Albuquerque EX, Pereira EF, Aracava Y, Fawcett WP, Oliveira M, Randall WR, Hamilton TA, Kan RK, Romano JA Jr, Adler M.

Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13220-5. Epub 2006 Aug 16.

11.

Nicotinic mechanisms contribute to soman-induced symptoms and lethality.

Hassel B.

Neurotoxicology. 2006 Jul;27(4):501-7. Epub 2006 Feb 24.

PMID:
16500708
12.
13.

Cholinergic modulation of hippocampal cells and circuits.

Cobb SR, Davies CH.

J Physiol. 2005 Jan 1;562(Pt 1):81-8. Epub 2004 Nov 4. Review.

14.
15.

Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling.

Fukudome Y, Ohno-Shosaku T, Matsui M, Omori Y, Fukaya M, Tsubokawa H, Taketo MM, Watanabe M, Manabe T, Kano M.

Eur J Neurosci. 2004 May;19(10):2682-92.

PMID:
15147302
16.
17.

Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors.

Santos MD, Pereira EF, Aracava Y, Castro NG, Fawcett WP, Randall WR, Albuquerque EX.

J Pharmacol Exp Ther. 2003 Jan;304(1):254-65.

18.

Unconventional ligands and modulators of nicotinic receptors.

Pereira EF, Hilmas C, Santos MD, Alkondon M, Maelicke A, Albuquerque EX.

J Neurobiol. 2002 Dec;53(4):479-500. Review.

19.

Hippocampal GABAergic interneurons: a physiological perspective.

Buzsáki G.

Neurochem Res. 2001 Sep;26(8-9):899-905. Review.

PMID:
11699941
20.

Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality.

Duysen EG, Li B, Xie W, Schopfer LM, Anderson RS, Broomfield CA, Lockridge O.

J Pharmacol Exp Ther. 2001 Nov;299(2):528-35.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk